TY - JOUR T1 - Multicentric and collaborative study of Spanish neurosurgical management of pediatric craniopharyngiomas: S-PedCPG.co JO - Neurocirugía T2 - AU - Iglesias,Sara AU - Munarriz,Pablo M. AU - Saceda,Javier AU - Catalán-Uribarrena,Gregorio AU - Miranda,Pablo AU - Vidal,Juana M. AU - Fustero,David AU - Giménez-Pando,Jorge AU - Rius,Francisca SN - 11301473 M3 - 10.1016/j.neucir.2022.01.003 DO - 10.1016/j.neucir.2022.01.003 UR - https://www.revistaneurocirugia.com/es-multicentric-collaborative-study-spanish-neurosurgical-articulo-S1130147322000082 AB - PurposeTo present a descriptive analysis of pediatric craniopharyngiomas (PedCPG) treated in various Spanish hospitals, defining factors related to recurrence and performing a critical analysis of the results. MethodsWe undertook a multicenter retrospective review of PedCPG treated between 2000 and 2017. Data collected included epidemiological variables, clinical and radiological characteristics, goal of first surgery, rate of recurrence and its approach, adjuvant treatment, complications and permanent morbidity. Associations were studied between progression and number of progressions and independent variables. ResultsThe study involved 69 children from 8 Spanish hospitals. Most of the tumors invaded several intracranial compartments at diagnosis, with the hypothalamus involved in 41.3% of cases. The first treatment strategy was usually gross total resection (GTR) (71%), with some patients treated with radiotherapy or intracystic chemotherapy. The progression rate after first surgery was 53% in a mean follow-up of 88.2 months (range 7–357). In the GTR group 38.8% of tumors recurred, 40% in the group of subtotal resection or biopsy and 93.3% in the cyst fenestration±Ommaya reservoir group. Mortality was 7.2%. Follow-up period, size of the tumor and goal of first surgery were significantly related with progression. ConclusionsOur results in terms of disease control, hormonal or visual impairment and mortality were acceptable, but there are several areas for improvement. Our short-term goals should be to create a national register of PedCPG, reach a consensus about a treatment algorithm, and improve diagnosis of hypothalamic dysfunction to avoid preventable morbidity. ER -